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Andrey A. Panteleyev1A detailed characterization of the normal (in situ) human hair follicle cycle,
supplemented with expressional data on speciﬁc hair follicle markers, has been
awaited by basic hair researchers and dermatologists. Combining this hair cycle
guide, together with a thorough analysis of the human-on-mouse hair xenograft
model, provides solid ground for examining human hair cycle biology and
pathology and for hair cycle-related pharmacological testing.
Journal of Investigative Dermatology (2016) 136, 4e6. doi:10.1016/j.jid.2015.10.052The development of appropriate labo-
ratory models is an essential step in
the exploration of any biological pro-
cess. Among the major advantages of
research models are simplicity and cost
efficiency, lack of ethical problems,
an ability to manipulate the model
according to need, as well as the
observation of dynamic effects, easy
interpretation of results, and, most
importantly, reproducibility (experi-
mental standardization) and accurate
quantification. However, modeling at
the level of tissues and organs (espe-
cially those with high humoral depen-
dence) is a challenge, and that is where
ex vivo and in vivo models are of great
advantage. All of this applies to the hu-
man hair follicle cycle, which is driven
by complex mechanisms (Stenn and
Paus, 2001) and is highly dependent on
hormonal action (Paus et al., 2014).
Since the beginning of the 20th century,
mouse pelage follicles and vibrissae
have remained the chief experimental
model for human hair research. How-
ever, mouse skin differs from human
skin, not only in certain hair cycle de-
tails (Oh et al., 2016), but in some basic
(and clinically relevant) aspects of skin
function as well, especially in immu-
nology, stem cell activity, and hormonal
dependence. This limits the use of the
mouse hair cycle model for studies of
human hair pathology and for pharma-
cological testing.
Considering the above, persistent at-
tempts to replicate various aspects of1Kurchatov Institute, Moscow, Russia
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mental settings are not surprising. For
example, the kidney capsule model
appeared to be adequate for studies of
hair follicle regeneration (Matsuzaki
and Yoshizato, 1998). Then, implanta-
tion of isolated human pilosebaceous
units into 3D skin equivalents in vitro
was shown to support hair follicle
viability (Michel et al., 1999). Mainte-
nance of isolated human anagen folli-
cles in culture using various matrix
beds (organoid culture) demonstrated
hair shaft elongation (anagen-like
progression) for a relatively long period
of time (Philpott et al., 1990), even
enabling some degree of postanagen
degeneration of cultured follicles
(Kloepper et al., 2010).
Histoculture of human full thickness
skin grown on a gelatin sponge matrix
(Li et al., 1992) has been shown to
provide more adequate environment
when compared with the culture of
isolated follicles, and eventually, it has
supported more intensive and pro-
longed hair shaft elongation. Some
follicles in this ex vivo system retain
proliferative capability for up to 40 days
(although mainly in the outer root
sheath, not in the hair bulb). More
importantly, some of these follicles un-
dergo spontaneous catagen-like trans-
formation, thus providing, similarly to
human hair follicle organoid culture,
the possibility of assessing and manip-
ulating certain aspects of the anagen-
catagen transition. Nevertheless, thisolecular Biology, Kurchatov Institute,
sia. E-mail: a.a.pantel@gmail.com
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follicles in vitro exhibits one major
limitation in common with other
in vitro models: it is incapable of
replicating the normal human hair cy-
cle in its entirety, especially its most
intriguing and clinically important
stage, the telogen-anagen transition
driven by hair germ/bulge/follicular
papilla crosstalk. In 2001, Stenn and
Paus noted: “A major current challenge
for the laboratory assessment of hair
follicle growth is to have inexpensive,
biologically relevant systems for
assessing hair follicle cycling. No such
system is now available” (Stenn and
Paus, 2001). Now, 14 years later, this
challenge remains.
In the early seventies, Reed and
Manning (1973) performed grafting of
normal full thickness human skin onto
congenitally athymic (nude) mice, thus
introducing a xenograft model for
human skin studies. The survival time of
human skin grafts on mouse recipients
appeared to be lifelong. Moreover, these
mice, with a compromised immune
system, were able to accept and main-
tain not only human, but also bird and
lizard skin, with a relatively high level of
graft survival. In the following years, the
xenotransplantation model was used
extensively to study human skin. These
studies addressed pharmacology, im-
munity, wound healing, transgene de-
livery to the skin, bacterial infection, and
cancer, as well as diseases such as ich-
thyosis and psoriasis.With respect to the
hair follicle, only alopecias of different
types (Gilhar and Krueger, 1987) and
the regenerative ability of follicles
have been studied using full thickness
human skin or isolated follicle xeno-
transplantation (Jahoda et al., 1996).
In 1996, Van Neste and colleagues
(the group that contributed immensely
to the development of human skin
xenotransplantation technique) de-
monstrated that follicles in skin xeno-
grafts not only produce normally
appearing hair shafts but also transit
through all stages of the cycle (Van
Neste et al., 1996). This group also
proposed that human skin or follicles
grafted onto nude mice may serve
as a useful tool for pharmacological
manipulation of hair growth. Surpris-
ingly, during the following twoc. on behalf of the Society for Investigative Dermatology.
Clinical Implications
 Xenografting diseased human skin onto severe combined immunodeficiency
mice can be used for modeling and for experimental studies of human hair
disorders.
 The xenograft model of normal human hair cycling is an efficient tool for
pharmacological testing of hair cycle modulating drugs.
 The guide for the human hair follicle cycle helps immensely in identifying
human hair follicle stages in everyday dermatopathology practice as well as in
preclinical and clinical studies.
COMMENTARYdecades, this xenotransplantation
model was not used to study the human
hair cycle or for testing cycle-targeting
pharmacologic agents. Among the only
exceptions were the publication by
Hashimoto et al. (2000), who per-
formed the first (and until now the only)
assessment of morphological changes
in surgically isolated scalp follicles
grafted onto severe combined immu-
nodeficiency (SCID) mice, and the
study aiming to identify stem cells in
human hair follicles at different stages
of the cycle (Lyle et al., 1999). One of
the obvious reasons for this imbalance
between the potential value of the
xenotransplantation model and its
underuse for hair cycle research was
the lack of systemic analyses of post-
grafting hair follicle transformation
through all cycle stages and, hence, the
inability to compare the natural human
hair follicle cycle and its pattern in
xenografts. Thus, potentially the best
research and preclinical testing model
of the human hair cycle remained
invalidated.
The work by Oh et al. (2016) fills
this gap. On the basis of the assess-
ment of more than a thousand human
anagen hair follicles grafted onto
nude and SCID mice, the authors
describe follicular morphology at 45
consecutive time points between days 2
and 402 after grafting. It provides an
opportunity to identify morphological
features specific for all hair follicle
structures and layers at all phases of
hair transition through defined sub-
stages of catagen, telogen, and anagen.
These morphological features are illus-
trated by histological images that are
accompanied by comprehensive sche-
matic drawings. In addition, the report
provides valuable information on the
optimization of the model, and iden-
tifies postgrafting time intervalsrepresentative for specific stages of the
human hair cycle. Comparison of nude
and SCID mice for their ability to
maintain human skin grafts and to
support postgrafting hair follicles re-
covery and cycling identifies SCID
mice as the model of choice. All of the
above raise the value of the human skin
xenograft model, transforming it into an
efficient tool to study the human hair
follicle cycle and to test cycle-
modulating drugs for their efficiency.
Nevertheless, to fully exploit the ad-
vantages of the human skin xenograft
model of the hair follicle cycle and to
envision its inevitable (but, it is hoped,
minor) limitations, it should be
compared carefully with the normal (in
situ) human hair follicle cycle. This is
where another significant gap in the
methodology of the human hair cycle
research has become apparent. Sur-
prisingly, since the classical publica-
tions by H.B. Chase and A.M. Kligman,
dating back to the 1950s, no systematic
attempts have been undertaken to pre-
sent a comprehensive, detailed, and
fully illustrated description and analysis
of the morphological changes that
normal human hair follicles go through
during the phases of the cycle. In fact,
the xenograft model of the human hair
cycle had nothing with which to be
compared. This problem is also
addressed by Oh et al. (2016). Their
“Guide to studying human hair follicle
cycling” literally hits two targets at
once: they not only reintroduce, char-
acterize, and validate the xenograft
human hair follicle cycle model, but
also provide a detailed step-by-step
description of the morphological
changes in all the functional parts of the
pilosebaceous unit during the normal
hair cycle. They also instruct how to use
these morphological features for pre-
cise staging of follicles. To make theanalysis of the normal human follicle
cycle easier, the Guide is illustrated
by histology photographs, 3D micro-
images, and expressional localization
of hair-specific markers (immunofluo-
rescence). Comprehensive schematic
drawings for every defined stage of the
hair cycle make understanding and
appreciating the data easy and capti-
vating. Parallel depiction of follicle
changes during normal (in situ) and
xenograft hair cycles (Oh et al., 2016;
Figures 1e4) helps immensely to vali-
date the xenograft model. This type of
comparison may also serve as a blue-
print for the validation of upcoming
in vitro models for human hair follicle
neogenesis and cycling, which are long
awaited and would be the answer to the
challenge outlined by Stenn and Paus in
2001 (see above).
All of the above makes the Guide by
Oh and co-authors probably the first
work providing comprehensive and
unifying picture of the human hair
cycle in all of its complexity. At the
same time, this Guide (especially the
staging of the human hair cycle and
interpretations of certain morphoge-
netic events) should not be viewed as
indisputable dogma, but rather as solid
ground for future endeavors into un-
derstanding human hair.
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consequences of vitiligo.See related article on pg 52Measuring the Impact of
Vitiligo: Behind the White Spots
Reinhart Speeckaert1, Jo Lambert1 and Nanja van Geel1The impact of vitiligo is generally believed to be underestimated. Salzes et al.
propose a questionnaire to measure the actual burden of vitiligo. Using a
stepwise approach they constructed and validated this instrument taking into
account the differences between fair and dark skin phototypes. It is a promising
approach that can be implemented on an international scale.
Journal of Investigative Dermatology (2016) 136, 6e7. doi:10.1038/JID.2015.407The impact of a cutaneous disorder on
the quality of life is essential for justi-
fying the need for new treatments and
attracting additional resources for
research. Moreover, from a political
point of view, improvement in the
quality of life is an objective criterion to
determine the cost-effectiveness of
treatment. Some general measurement
tools have been developed for skin
disorders (e.g., dermatology life quality
index, Skindex, etc.). However, as the
spectrum of dermatological diseases is
broad, these more global instruments
are often insufficient (Twiss et al.,
2012).
Vitiligo has a tendency to develop at
visible parts of the body such as the
hands and the face, which are socially
important. Many studies have shown areduced quality of life in patients with
vitiligo, but other studies have not
confirmed a substantial impact of viti-
ligo on life quality. This may be due to
the fact that the generally accepted
dermatological questionnaires such as
the dermatology life quality index and
Skindex-16 lack the sensitivity needed
for a disorder without symptoms such
as pruritus or pain. The first four ques-
tions of the Skindex-16 involve skin
itching, burning, hurting, and irritation
that are not relevant to vitiligo. More-
over, the dermatology life quality index
and Skindex-16 focus in each question
on the complaints the patient had last
week. Although this is appropriate for
patients with skin disorders exhibiting
disease flares and remissions, this is not
ideal for chronic progressive disorders.ital, Ghent, Belgium
Dermatology, Ghent University Hospital,
nhart.Speeckaert@UGent.be
e 136In a number of skin disorders (such as
psoriasis, atopic dermatitis, and acne),
tailored life impact tools have been
developed to describe the disease
burden more accurately.Salzes et al. (2016) report the devel-
opment and validation of a new tool to
assess the burden of vitiligo. In contrast
to most dermatological disorders, viti-
ligo lacks clear inflammatory signs such
as redness, scaling, and itch. This may
lead to the misperception that the
impact of the disease on daily life is
low. It is rather unfortunate that several
different vitiligo impact scores have
been published in the last several years
with only limited international collab-
oration. Krishna et al. (2013) proposed
a vitiligo impact score—subsequently
adapted into a 22-item scale (Vitiligo
Impact Scale-22)—that is quite different
from the Vitiligo Impact Patient scale
(Gupta et al., 2014; Krishna et al.,
2013). However, these studies were
conducted in India, and they reference
issues not relevant to patients in other
parts of the world: concerns about
contagiousness, people who deliber-
ately avoid contact with patients, and
marital issues related to local mis-
perceptions and social stigma toward
dermatological disorders. Lilly et al.
(2013) validated a vitiligo-specific
health-related quality of life instrument,
using a study population with mainly
dark skin (n¼ 90; 65% skin type IVeVI).
The vitiligo-specific health-related
quality of life instrument scale was
recently also validated in Brazilian Por-
tuguese patients with vitiligo (Boza
et al., 2015). This scale resembles the
Vitiligo Impact Patient scale with 12 of
16 questions of the vitiligo-specific
health-related quality of life instrument
